tirzepatide microdose protocol Microdosing Chart Question: My first 8 week
Description
Schedule: Patients usually begin at 0.75 mg and then increase their dose weekly to improve its effectiveness while minimizing side effects
No funding was received for this study or to assist with the preparation of this manuscript
Recent studies have examined whether semaglutide use may be associated with a higher risk of developing NAION
Oral semaglutide (Wegovy) is now FDA-approved for weight loss
For instance, the FDA approved Ozempic in March 2024 to prevent heart complications in overweight and obese adults
